(APEI) American Public Education - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US02913V1035
Stock: Degree, Certificate, Nursing, Online, Campus
Total Rating 73
Risk 92
Buy Signal 1.77
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 53.2% |
| Relative Tail Risk | -13.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.59 |
| Alpha | 83.38 |
| Character TTM | |
|---|---|
| Beta | 0.749 |
| Beta Downside | 0.728 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.99% |
| CAGR/Max DD | 0.71 |
Description: APEI American Public Education December 27, 2025
American Public Education, Inc. (NASDAQ: APEI) operates three education brands-American Public University System, Rasmussen University, and Hondros College of Nursing-offering 182 degree and 136 certificate programs across fields such as nursing, national security, business, and IT. The firm serves both civilian and federal-government workforces, leveraging online and campus formats, and has been publicly traded since its 1991 incorporation in Charles Town, West Virginia.
Key quantitative signals (as of the most recent FY 2024 filing) include a 7 % YoY increase in total enrollment, driven largely by GI Bill-eligible veterans, and a revenue run-rate of roughly $620 million with an operating margin hovering near 12 %. The company’s debt-to-EBITDA ratio sits at ~2.1×, indicating moderate leverage. Sector-wide, federal education spending and the persistent nursing shortage remain primary growth catalysts, while competition from low-cost online providers poses a downside risk.
For a deeper dive into APEI’s valuation multiples and forward-looking financial models, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 31.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 7.55 > 1.0 |
| NWC/Revenue: 25.62% < 20% (prev 23.99%; Δ 1.63% < -1%) |
| CFO/TA 0.14 > 3% & CFO 75.1m > Net Income 31.9m |
| Net Debt (-25.1m) to EBITDA (66.4m): -0.38 < 3 |
| Current Ratio: 2.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.8m) vs 12m ago 2.78% < -2% |
| Gross Margin: 54.22% > 18% (prev 0.52%; Δ 5370 % > 0.5%) |
| Asset Turnover: 119.6% > 50% (prev 107.7%; Δ 11.92% > 0%) |
| Interest Coverage Ratio: 13.85 > 6 (EBITDA TTM 66.4m / Interest Expense TTM 3.65m) |
Altman Z'' 2.41
| A: 0.32 (Total Current Assets 259.1m - Total Current Liabilities 91.4m) / Total Assets 525.3m |
| B: -0.06 (Retained Earnings -29.1m / Total Assets 525.3m) |
| C: 0.09 (EBIT TTM 50.5m / Avg Total Assets 547.4m) |
| D: -0.12 (Book Value of Equity -29.0m / Total Liabilities 246.0m) |
| Altman-Z'' Score: 2.41 = A |
Beneish M -3.09
| DSRI: 1.01 (Receivables 51.5m/48.0m, Revenue 654.6m/613.3m) |
| GMI: 0.96 (GM 54.22% / 51.93%) |
| AQI: 1.02 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 1.07 (Revenue 654.6m / 613.3m) |
| TATA: -0.08 (NI 31.9m - CFO 75.1m) / TA 525.3m) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of APEI shares?
As of January 30, 2026, the stock is trading at USD 42.27 with a total of 156,850 shares traded.
Over the past week, the price has changed by -3.32%, over one month by +12.51%, over three months by +24.95% and over the past year by +95.06%.
Over the past week, the price has changed by -3.32%, over one month by +12.51%, over three months by +24.95% and over the past year by +95.06%.
Is APEI a buy, sell or hold?
American Public Education has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy APEI.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the APEI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.2 | -2.6% |
| Analysts Target Price | 41.2 | -2.6% |
| ValueRay Target Price | 51.3 | 21.3% |
APEI Fundamental Data Overview January 24, 2026
P/E Trailing = 33.374
P/E Forward = 18.9036
P/S = 1.2078
P/B = 2.7522
P/EG = 1.2596
Revenue TTM = 654.6m USD
EBIT TTM = 50.5m USD
EBITDA TTM = 66.4m USD
Long Term Debt = 94.4m USD (from longTermDebt, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last quarter)
Debt = 166.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.1m USD (from netDebt column, last quarter)
Enterprise Value = 765.6m USD (790.7m + Debt 166.2m - CCE 191.3m)
Interest Coverage Ratio = 13.85 (Ebit TTM 50.5m / Interest Expense TTM 3.65m)
EV/FCF = 12.77x (Enterprise Value 765.6m / FCF TTM 60.0m)
FCF Yield = 7.83% (FCF TTM 60.0m / Enterprise Value 765.6m)
FCF Margin = 9.16% (FCF TTM 60.0m / Revenue TTM 654.6m)
Net Margin = 4.87% (Net Income TTM 31.9m / Revenue TTM 654.6m)
Gross Margin = 54.22% ((Revenue TTM 654.6m - Cost of Revenue TTM 299.7m) / Revenue TTM)
Gross Margin QoQ = 54.23% (prev 51.82%)
Tobins Q-Ratio = 1.46 (Enterprise Value 765.6m / Total Assets 525.3m)
Interest Expense / Debt = 0.64% (Interest Expense 1.07m / Debt 166.2m)
Taxrate = 35.56% (3.07m / 8.63m)
NOPAT = 32.6m (EBIT 50.5m * (1 - 35.56%))
Current Ratio = 2.84 (Total Current Assets 259.1m / Total Current Liabilities 91.4m)
Debt / Equity = 0.60 (Debt 166.2m / totalStockholderEquity, last quarter 279.3m)
Debt / EBITDA = -0.38 (Net Debt -25.1m / EBITDA 66.4m)
Debt / FCF = -0.42 (Net Debt -25.1m / FCF TTM 60.0m)
Total Stockholder Equity = 291.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.83% (Net Income 31.9m / Total Assets 525.3m)
RoE = 10.95% (Net Income TTM 31.9m / Total Stockholder Equity 291.4m)
RoCE = 13.10% (EBIT 50.5m / Capital Employed (Equity 291.4m + L.T.Debt 94.4m))
RoIC = 8.91% (NOPAT 32.6m / Invested Capital 365.4m)
WACC = 7.24% (E(790.7m)/V(956.9m) * Re(8.68%) + D(166.2m)/V(956.9m) * Rd(0.64%) * (1-Tc(0.36)))
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.37%
[DCF Debug] Terminal Value 83.76% ; FCFF base≈44.8m ; Y1≈55.2m ; Y5≈94.1m
Fair Price DCF = 105.1 (EV 1.88b - Net Debt -25.1m = Equity 1.90b / Shares 18.1m; r=7.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 8.82 | EPS CAGR: -2.37% | SUE: -2.64 | # QB: 0
Revenue Correlation: 71.30 | Revenue CAGR: 1.56% | SUE: 1.65 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.61 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.73 | Chg30d=-0.060 | Revisions Net=+0 | Growth EPS=+46.8% | Growth Revenue=+7.2%
P/E Forward = 18.9036
P/S = 1.2078
P/B = 2.7522
P/EG = 1.2596
Revenue TTM = 654.6m USD
EBIT TTM = 50.5m USD
EBITDA TTM = 66.4m USD
Long Term Debt = 94.4m USD (from longTermDebt, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last quarter)
Debt = 166.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.1m USD (from netDebt column, last quarter)
Enterprise Value = 765.6m USD (790.7m + Debt 166.2m - CCE 191.3m)
Interest Coverage Ratio = 13.85 (Ebit TTM 50.5m / Interest Expense TTM 3.65m)
EV/FCF = 12.77x (Enterprise Value 765.6m / FCF TTM 60.0m)
FCF Yield = 7.83% (FCF TTM 60.0m / Enterprise Value 765.6m)
FCF Margin = 9.16% (FCF TTM 60.0m / Revenue TTM 654.6m)
Net Margin = 4.87% (Net Income TTM 31.9m / Revenue TTM 654.6m)
Gross Margin = 54.22% ((Revenue TTM 654.6m - Cost of Revenue TTM 299.7m) / Revenue TTM)
Gross Margin QoQ = 54.23% (prev 51.82%)
Tobins Q-Ratio = 1.46 (Enterprise Value 765.6m / Total Assets 525.3m)
Interest Expense / Debt = 0.64% (Interest Expense 1.07m / Debt 166.2m)
Taxrate = 35.56% (3.07m / 8.63m)
NOPAT = 32.6m (EBIT 50.5m * (1 - 35.56%))
Current Ratio = 2.84 (Total Current Assets 259.1m / Total Current Liabilities 91.4m)
Debt / Equity = 0.60 (Debt 166.2m / totalStockholderEquity, last quarter 279.3m)
Debt / EBITDA = -0.38 (Net Debt -25.1m / EBITDA 66.4m)
Debt / FCF = -0.42 (Net Debt -25.1m / FCF TTM 60.0m)
Total Stockholder Equity = 291.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.83% (Net Income 31.9m / Total Assets 525.3m)
RoE = 10.95% (Net Income TTM 31.9m / Total Stockholder Equity 291.4m)
RoCE = 13.10% (EBIT 50.5m / Capital Employed (Equity 291.4m + L.T.Debt 94.4m))
RoIC = 8.91% (NOPAT 32.6m / Invested Capital 365.4m)
WACC = 7.24% (E(790.7m)/V(956.9m) * Re(8.68%) + D(166.2m)/V(956.9m) * Rd(0.64%) * (1-Tc(0.36)))
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.37%
[DCF Debug] Terminal Value 83.76% ; FCFF base≈44.8m ; Y1≈55.2m ; Y5≈94.1m
Fair Price DCF = 105.1 (EV 1.88b - Net Debt -25.1m = Equity 1.90b / Shares 18.1m; r=7.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 8.82 | EPS CAGR: -2.37% | SUE: -2.64 | # QB: 0
Revenue Correlation: 71.30 | Revenue CAGR: 1.56% | SUE: 1.65 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.61 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.73 | Chg30d=-0.060 | Revisions Net=+0 | Growth EPS=+46.8% | Growth Revenue=+7.2%